Patients who struggle with self-management—for example due to dementia—experience 2-3 times more emergency department visits and hospitalizations than those who are able to self-manage. These types of acute events accelerate cognitive and functional decline and perpetuate a cycle of more acute events and further declines.
Family caregivers (e.g., spouses or adult children) are often stressed and inexperienced. Managed care organizations are unable to engage these patients directly and lack programs that can effectively integrate a family caregiver into the patient’s care.
Our novel approach combines technology, content, coaching and analytics to empower family caregivers to become more active and effective in managing a loved one’s care. We personalize the elements of our approach for every patient/caregiver dyad that is enrolled in our digital health programs.
We empower caregivers by engaging them in a program of personalized education, support, and coaching that is delivered via a tablet device that we send to the home. A typical caregiver engages in their Ceresti program for an hour every week and develops the knowledge, skills and confidence required to take a more active role in managing their loved one’s health.
We remotely monitor patients daily via a risk assessment that detects the early warning signs of potential acute events. Caregivers engaged in our program complete an average of 3 risk assessment per week. Risk assessments are dynamically created by Ceresti’s proprietary AI/personalization engine based on multiple data inputs, including claims data, and prior medical, psychosocial and behavioral issues reported by the caregiver.
An actionable alert is generated when a caregiver’s risk assessment triggers a “red flag.” Ceresti’s coaching team resolves the majority of alerts by suggesting specific actions for the caregiver that are supported by real-time education and coaching. We also coordinate risk mitigation with care managers or the patient’s providers.
Our digital health program is integrated into a modular solution that includes claims analysis and program enrollment. Our targeted approach, informed by claims data, identifies patient/caregiver dyads that have a high risk of an acute event and aims to enroll them in our digital health program. Those dyads with a lower risk of an acute event are offered access to our education portal and can call our coaching team for support. We track eligible patients longitudinally to reflect their changing acute event risk and ensure that they have access to the appropriate intervention.
Ceresti Health is a team of experienced and passionate professionals focused on improving cost and quality outcomes for patients with multiple chronic conditions, starting with those who also have Alzheimer’s Disease or other dementias. We have developed a scalable technology-enabled family caregiver empowerment program that leverages family caregivers to optimize and supplement payer/provider care management teams in managing one of the most expensive, rapidly growing and difficult to manage populations.
Dirk Soenksen is a strategic results-oriented healthcare executive with over 25 years experience. Prior to Ceresti, Mr. Soenksen founded venture-backed Aperio and served in the positions of President/CEO/Chairman until its acquisition by Danaher/Leica Biosystems in 2012. He built a winning team that established Aperio as the recognized global leader in digital pathology, with a staff of 200, a rich portfolio of patents, healthy and growing revenue, multiple FDA clearances, and an installed base of more than 1,000 systems in 35 countries. He earned his AB degree in Chemistry from Bowdoin College, MSEE from the University of Pennsylvania, and his MBA from Pepperdine University.
Mark Wrenn has over 30 years experience developing reliable and scalable software architectures. Before co-founding Ceresti, Mr. Wrenn was Sr. Director of Product and Business Development at Aperio where he led the development of a global, HIPAA compliant, cloud-based second opinion network for pathology. He also served as Director of Professional Services where he delivered value-added software and services, including interfaces to third-party IT systems, for a pathology PACS. He earned his BSEng in Computer Science from the University of Connecticut.
Chris Selecky has more than 30 years of experience in managed care and population health management and is Chair of the Board of the Population Health Alliance, the national trade association of the Population Health industry. She is an innovative and accomplished chief executive and entrepreneur in the healthcare industry including co-founding and growing a market leading disease management company from start-up to $130 million in revenues and leading a $2 billion business unit of a publicly traded managed care organization.
She serves on for-profit boards of directors and provides strategic consulting and advice to management teams and investors currently in or seeking to enter the healthcare field. Her areas of expertise include population health management, wellness and prevention, care coordination, disease management, commercial and Medicare managed care, and delivery system management.
Rob Lonardo has more than 35 years of experience in managed care with an emphasis on Medicare Advantage, Dual Eligibles and SPD (Seniors and Persons with Disabilities) populations. Rob’s career has included leadership roles at FHP Healthcare, Blue Shield of California and running a large IPA serving the Inland Empire and San Diego markets. Rob led CareMore Medical Enterprises for nearly 6 years, initially working for its physician owners, and subsequently running Growth and Business Development after Anthem’s acquisition of CareMore. Most recently, he worked at Alignment Healthcare in Orange, CA serving in multiple leadership roles.
Rob has a true passion for changing the way care is delivered, particularly to seniors. He has been a leader in improved coordination of care, better use of technology, using data to help health plans ‘find’ the patients that need them most, and assuring that every member with any disease or condition gets the care they need when and where it should be delivered.
Dr. Norman has 30 years of experience in population health, value-based care, and provider transformation. His career has focused on supporting provider & health systems, ACOs, and health plans as they pivot to the value-based care era where cost efficiency, quality outcomes, and experience of care are balanced to formulate the overall value of health care delivery.
Most recently, Dr. Norman led the Health System Consulting practice at Willis Towers Watson where he worked directly with health systems transitioning to value-based care. Previously, he served as Chief Medical Officer for xG Health Solutions, where he adapted and disseminated the value-based care know-how and tools developed by Geisinger Health System for other delivery systems transforming from fee-for-volume to fee-for-value care models. Before that, he held a series of executive leadership roles in multiple sectors of the healthcare ecosystem, with a consistent focus on population health management and value improvement.
While we are squarely focused on improving patient care and reducing healthcare costs, our broader mission is to change the conversation around dementia. We believe there is a compelling opportunity to align Ceresti’s solutions with national initiatives aimed at finding a cure for Alzheimer’s Disease. For example, our family caregiver empowerment programs can potentially reduce U.S. healthcare costs by hundreds of billions of dollars over the course of a decade. Redirecting these savings to finding a cure could result in a more than 10-fold increase over current funding levels.
We also believe that our solutions could be deployed with new or existing treatment agents to enable new treatments for Alzheimer’s Disease, a disease area that has seen no new drug approvals since 2003.